-
Data show steady drop-off in protection with Pfizer's COVID-19 vaccine
firstwordpharma
July 29, 2021
The effectiveness of Pfizer and partner BioNTech's coronavirus vaccine BNT162b2 steadily declines over time, slipping to roughly 84% for vaccinated people about four to six months after they got their second dose, according to data released Wednesday.
-
MetrioPharm Selected by European Commission for Funding as Part of the "HERA Incubator”
b3cnewswire
July 29, 2021
MetrioPharm AG, a pharmaceutical company developing drugs for chronic inflammatory diseases, has been nominated to receive funding under the HERA Incubator from the European Commission under Grant Agreement number 101046182.
-
Biocon Biologics and Adagio Therapeutics to develop antibody treatment for COVID-19
expresspharma
July 28, 2021
Biocon Biologics to manufacture and commercialise a broadly neutralising antibody for India and select emerging markets.
-
Severe COVID for People Under 45: Who's Most at Risk?
drugs
July 28, 2021
Young people aren't immune from severe COVID-19, and a new study warns that some are more at risk than others.
-
Federal, State Agencies Begin to Mandate COVID-19 Vaccines for Workers
drugs
July 28, 2021
In a sign that the United States has reached a "tipping point" in its campaign to vaccinate Americans, California and New York City announced vaccine or testing mandates for their employees on Monday, while the Department of Veterans Affairs
-
Despite Reopening, Britain Sees Six Straight Days of Declines in COVID-19 Cases
drugs
July 28, 2021
COVID-19 cases in Britain have fallen for six days in a row, even though the government lifted all but a few social-distancing restrictions last week.
-
Second COVID-19 mRNA vaccine dose found safe following allergic reactions to first dose
firstwordpharma
July 28, 2021
In a multi-hospital analysis of individuals who experienced an allergic reaction to their first mRNA COVID-19 vaccine dose, all patients who went on to receive a second dose tolerated it without complications.
-
Opteev Launches the First-Ever Plug-In Airborne Virus Detector that Immediately Alerts when COVID-19, the Flu and Other Viruses Are Found
prnewswire
July 28, 2021
To help stop the spread of COVID-19, new variants and other viruses, today Opteev, the leading personal health safety and virus screening technology company, announced the launch of ViraWarn™, the first ever plug-in screening device for detecting airborne
-
iXensor Levels Up PixoTest Covid-19 Ag Test With The Launch Of PixoHealth Data Management Platform As The Security Solution For The New Normalcy
prnewswire
July 28, 2021
iXensor Co., Ltd. (6734.TWO) launches the next generation of integrated COVID-19 screening solution, the PixoHealth Pass Admin App and Web Portal.
-
Arrow Reports $13.3 million in Q2 Net Income as COVID-19 Recovery Continues
prnewswire
July 28, 2021
Arrow Financial Corporation (NasdaqGS® – AROW) announced operating results for the three and six-month periods ended June 30, 2021. Net income for the second quarter of 2021 was $13.3 million, compared to $9.2 million in the second quarter of 2020.